Sildenafil treatment attenuates ventricular remodeling in an experimental model of aortic regurgitation-Reference-Cited by-同舟云学术

Sildenafil treatment attenuates ventricular remodeling in an experimental model of aortic regurgitation

Published:2015-10-13 Issue:1 Volume:4 Page:
ISSN:2193-1801
Container-title:SpringerPlus
language:en
Short-container-title:SpringerPlus

Author:

Eskesen Kristian^ORCID,Olsen Niels Thue,Dimaano Veronica L.,Fritz-Hansen Thomas,Sogaard Peter,Chakir Khalid,Steenbergen Charles,Kass David,Abraham Theodore P.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://link.springer.com/content/pdf/10.1186/s40064-015-1317-8.pdf

Reference29 articles.

1. Arsenault M, Plante E, Drolet M-C, Couet J (2002) Experimental aortic regurgitation in rats under echocardiographic guidance. J Heart Valve Dis 11:128–134

2. Bernardo BC, Weeks KL, Pretorius L, McMullen JR (2010) Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacol Ther 128:191–227. doi: 10.1016/j.pharmthera.2010.04.005

3. Bonow RO, Rosing DR, Maron BJ et al (1984) Reversal of left ventricular dysfunction after aortic valve replacement for chronic aortic regurgitation: influence of duration of preoperative left ventricular dysfunction. Circulation 70:570–579

4. Bonow RO, Picone AL, McIntosh CL et al (1985) Survival and functional results after valve replacement for aortic regurgitation from 1976 to 1983: impact of preoperative left ventricular function. Circulation 72:1244–1256. doi: 10.1161/01.CIR.72.6.1244

5. Bonow RO, Carabello BA, Chatterjee K et al (2008) 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 52:e1–e142. doi: 10.1016/j.jacc.2008.05.007

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of phosphodiesterase‐5 inhibition or angiotensin‐converting enzyme inhibition on right and left ventricular remodeling in heart failure due to chronic volume overload;Pharmacology Research & Perspectives;2024-01-29

2. Modified Heterotopic Abdominal Heart Transplantation and a Novel Aortic Regurgitation Model in Rats;Journal of Visualized Experiments;2023-06-02

3. Safety and Efficacy of Sildenafil for Group 2 Pulmonary Hypertension in Left Heart Failure;Children;2023-01-31

4. Safety of Phosphodiesterase-5 Inhibitors in Valvular Heart Disease;Journal of Cardiovascular Pharmacology;2021-09

5. Role of Phosphodiesterase in the Biology and Pathology of Diabetes;International Journal of Molecular Sciences;2020-11-03